/PAX.ST
PAX.ST Stock - Paxman AB (publ)
Healthcare|Medical - DevicesSTO
$54.00-1.46%
$0.80 (-1.46%) • Dec 23
56
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.4
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $59.40
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for PAX.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$53.46 – $54.54
TARGET (TP)$62.10
STOP LOSS$49.68
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.47
52W High$85.80
52W Low$50.60
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $253.01M | $210.12M | $156.75M | $96.20M | $78.05M |
| Gross Profit | $175.42M | $146.42M | $101.44M | $64.52M | $50.69M |
| Gross Margin | 69.3% | 69.7% | 64.7% | 67.1% | 64.9% |
| Operating Income | $33.51M | $12.62M | $-1,216,000 | $-10,574,000 | $-11,690,000 |
| Net Income | $40.20M | $8.33M | $-10,324,000 | $-12,776,000 | $-19,186,000 |
| Net Margin | 15.9% | 4.0% | -6.6% | -13.3% | -24.6% |
| EPS | $2.11 | $0.44 | $-0.54 | $-0.73 | $-1.20 |
Company Overview
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment in Europe, the United States, Mexico, Japan, Oceania, rest of Asia, and South and Central America. It serves various cancer centers and hospitals. The comapny has a research collaboration agreement with National University Hospital, Singapore for the development of portable cooling and compression device. Paxman AB (publ) was founded in 1996 and is based in Karlshamn, Sweden.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
PAX.STBeat Rate
57%
Last 7 quarters
Avg Surprise
+33.4%
EPS vs Estimate
Beats / Misses
4/3
Last 12 quarters
Latest EPS
$0.06
Q4 2025
EPS Surprise History
Q4 23
+92.9%
$0.39vs$0.20
Q1 24
-117.3%
$-0.09vs$0.50
Q2 24
+245.0%
$0.69vs$0.20
Q3 24
+73.3%
$0.52vs$0.30
Q4 24
-56.7%
$0.26vs$0.60
Q1 25
+6.7%
$0.64vs$0.60
Q2 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $0.06 | — | — |
Q2 2025 | May 16, 2025 | — | $-0.29 | — | — |
Q1 2025 | Feb 21, 2025 | $0.60 | $0.64 | +6.7% | ✓ BEAT |
Q4 2024 | Nov 15, 2024 | $0.60 | $0.26 | -56.7% | ✗ MISS |
Q3 2024 | Aug 21, 2024 | $0.30 | $0.52 | +73.3% | ✓ BEAT |
Q2 2024 | May 23, 2024 | $0.20 | $0.69 | +245.0% | ✓ BEAT |
Q1 2024 | Feb 23, 2024 | $0.50 | $-0.09 | -117.3% | ✗ MISS |
Q4 2023 | Nov 17, 2023 | $0.20 | $0.39 | +92.9% | ✓ BEAT |
Q3 2023 | Aug 24, 2023 | $0.30 | $0.27 | -10.1% | ✗ MISS |
Q2 2023 | May 24, 2023 | — | $-0.13 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.49 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.24 | — | — |
Q2 2022 | Jun 30, 2022 | — | $0.03 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.33 | — | — |
Q1 2022 | Feb 25, 2022 | — | $-0.08 | — | — |
Q4 2021 | Nov 19, 2021 | — | $-0.30 | — | — |
Q3 2021 | Aug 27, 2021 | — | $-0.31 | — | — |
Q2 2021 | May 26, 2021 | — | $-0.22 | — | — |
Q1 2021 | Feb 26, 2021 | — | $-0.26 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.69 | — | — |
Latest News
Loading news...
Frequently Asked Questions about PAX.ST
What is PAX.ST's current stock price?
Paxman AB (publ) (PAX.ST) is currently trading at $54.00 per share. The stock has moved -1.46% today.
What is the analyst price target for PAX.ST?
No analyst price targets are currently available for this stock.
What sector is Paxman AB (publ) in?
Paxman AB (publ) operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the STO exchange.
What is PAX.ST's market cap?
Paxman AB (publ) has a market capitalization of $1.26 billion, making it a small-cap company.
Does PAX.ST pay dividends?
No, Paxman AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADDV-B.ST
ADDvise Group AB (publ)
$1.62
Mkt Cap: $1.0B
BICO.ST
BICO Group AB (publ)
$19.00
Mkt Cap: $1.3B
CRAD-B.ST
C-Rad AB (publ)
$31.85
Mkt Cap: $1.0B
DMYD-B.ST
Diamyd Medical AB (publ)
$10.08
Mkt Cap: $1.4B
GENO.ST
Genovis AB (publ.)
$21.20
Mkt Cap: $1.4B
OSSD.ST
OssDsign AB (publ)
$11.46
Mkt Cap: $1.3B
SEDANA.ST
Sedana Medical AB (publ)
$9.92
Mkt Cap: $1.0B
SEZI.ST
Senzime AB (publ)
$5.26
Mkt Cap: $0.8B
STIL.ST
Stille AB
$208.00
Mkt Cap: $1.9B
SYNACT.ST
SynAct Pharma AB
$23.80
Mkt Cap: $1.3B
Explore stocks similar to PAX.ST for comparison